Investigation of dissolution behavior of diclofenac sodium extended release formulations under standard and biorelevant test conditions

References

• Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS. (1980). Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs, 1:24–48.
   Google Scholar
• Lotsch J, Kettenmann B, Renner B, Drover D, Brune K, Geisslinger G, . (2000). Population pharmacokinetics of fast release oral diclofenac in healthy volunteers: Relation to pharmacodynamics in an experimental pain model. Pharm Res, 17:77–84.
   PubMed Web of Science ®Google Scholar
• Small RE. (1989). Diclofenac sodium. Clin Pharm, 8:545–58.
   PubMedGoogle Scholar
• Ho H, Liu CH, Lin HM, Sheu MT. (2003). The development of matrix tablets for diclofenac sodium based on an empirical in-vitro and in-vivo correlation. Int J Pharm, 251:67–78.
   PubMedGoogle Scholar
• Sheu MT, Chou HL, Kao CC, Liu CH, Sokoloski TD. (1992). Dissolution of diclofenac sodium from matrix tablets. Int J Pharm, 85:57–63.
   Google Scholar
• Chuasuwan B, Binjesoh V, Polli JE, Zhang H, Amidon GL, Junginger HE, . (2008). Biowaiver monographs for immediate release solid oral dosage forms: Diclofenac sodium and diclofenac potassium. J Pharm Sci, 7:5061–73.
   Google Scholar
• Llinàs A, Burley JC, Box KJ, Glen RC, Goodman JM. (2007). Diclofenac solubility: Independent determination of the intrinsic solubility of three crystal forms. J Med Chem, 50:979–83.
   PubMed Web of Science ®Google Scholar
• O'Connor KM, Corrigan OI. (2001). Preparation and characterisation of a range of diclofenac salts. Int J Pharm, 226:163–79.
   PubMed Web of Science ®Google Scholar
• Sobhan MA, Granqvist CG, Kivaisi RT, Stjerna B, Arpesella C, Broggini C, . (1996). Factors governing the dissolution of diclofenac salts. Eur J Pharm Sci, 4:231–8.
   Web of Science ®Google Scholar
• Garbacz G, Wedemeyer RS, Nagel S, Giessmann T, Mönnikes H, Wilson CG, . (2008). Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in-vivo physical stresses. Eur J Pharm Biopharm, 70:421–8.
   PubMed Web of Science ®Google Scholar
• Riad LE, Sawchuk RJ, McAlary MM, Chan KK. (1995). Effect of food on the multiple peak behavior after a single oral dose of diclofenac sodium slow-release tablet in humans. Am J Ther, 2:237–42.
   PubMedGoogle Scholar
• Vidon N, Pfeiffer A, Godbillon J, Rongier M, Gauron S, Hirtz J, . (1989). Evaluation of the gastric absorption and emptying of drugs under various pH conditions using a simple intubation method: Application to diclofenac. Br J Clin Pharmacol, 28:121–4.
   PubMed Web of Science ®Google Scholar
• Chan H, Mojaverian P, Ziehmer BA, John VA. (1990). Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteer. Pharm Res, 7:1026–32.
   PubMed Web of Science ®Google Scholar
• Liu H, Kao YH, Chen SC, Sokoloski TD, Sheu MT. (1995). In-vitro and in-vivo studies of diclofenac sodium controlled-release matrix tablets. J Pharm Pharmacol, 47:360–4.
   PubMed Web of Science ®Google Scholar
• Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. (1988). Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 29:1035–41.
   PubMed Web of Science ®Google Scholar
• Krajacic A, Tucker IG. (2003). Matrix formation in sustained release tablets: Possible mechanism of dose dumping. Int J Pharm, 251:67–78.
   PubMed Web of Science ®Google Scholar
• Weitschies W, Cordini D, Karaus M, Trahms L, Semmler W. (1999). Magnetic marker monitoring of the oesophageal, gastric and duodenal transit of nondisintegrating capsules. Pharmazie, 54:426–30.
   Google Scholar
• Weitschies W, Kosch O, Mönnikes H, Trahms L. (2005). Magnetic marker monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv Drug Deliv Rev, 57:1210–22.
   PubMed Web of Science ®Google Scholar
• Cassilly D, Kantor S, Knight LC, Maurer AH, Fisher RS, Semler J, . (2008). Gastric emptying of a non-digestible solid: Assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil, 20:311–9.
   PubMed Web of Science ®Google Scholar
• Dinning PG, Bampton PA, Kennedy ML, Kajimoto T, Lubowski DZ, de Carle DJ, . (1999). Basal pressure patterns and reflexive motor responses in the human ileocolonic junction. Am J Physiol, 276:G331–40.
   PubMed Web of Science ®Google Scholar
• Kamba M, Seta Y, Kusai A, Ikeda M, Nishimura K. (2000). A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract. Int J Pharm 208:61–70.
   PubMed Web of Science ®Google Scholar
• Schiller C, Frohlich CP, Giessman T, Siegmund W, Monnikes H, Hostein N, . (2005). Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther, 22:971–79.
   PubMed Web of Science ®Google Scholar
• Pillay V, Fassihi R. (1998). Evaluation and comparison of dissolution data derived from different modified release dosage forms: An alternative method. J Control Release, 55:45–55.
   PubMed Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products. (2001). Note for guidance on the investigation of bioavailability and bioequivalence CMP/EWP/QWP1401/98. EMEA, London.
   Google Scholar
• Committee for Proprietary Medicinal Products. (2008). Guideline on the investigation of bioequivalence CPMP/EWP/QWP/1401/98 Rev. 1. EMEA, London.
   Google Scholar
• Commission Regulation (EC). 2003. No 1084/2003. EMEA, London.
   Google Scholar
• Henderson JD, Esham RH. (2001). Generic substitution: Issues for problematic drugs. South Med J, 94:16–21.
   PubMed Web of Science ®Google Scholar
• Meredith P. (2003). Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther, 25:2875–90.
   PubMed Web of Science ®Google Scholar
• Bai G, Armenante PM. (2009). Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing. J Pharm Sci, 98:1511–31.
   PubMed Web of Science ®Google Scholar
• McCarthy GL, Bradley G, Sexton JC, Corrigan OI, Healy AM. (2004). Computational fluid dynamics modeling of the paddle dissolution apparatus: Agitation rate, mixing patterns, and fluid velocities. AAPS PharmSciTech, 5:e31.
   PubMed Web of Science ®Google Scholar
• Bertocchia P, Antoniellaa E, Valvoa E, Alimontia S, Memolib A. (2005). Diclofenac sodium multisource prolonged release tablets—a comparative study on the dissolution profiles. J Pharm Biomed Anal, 37:679–85.
   PubMed Web of Science ®Google Scholar
• Barreiro MA, McKenna RD, Beck IT. (1968). Determination of transit in the human jejunum by the single-injection indicator-dilution technique. Am J Dig Dis, 13:222–33.
   PubMedGoogle Scholar
• Duthie HL. (1978). Colonic response to eating. Gastroenterology, 75:527–8.
   PubMed Web of Science ®Google Scholar
• Spiller RC, Brown ML, Phillips SF. (1987). Emptying of the terminal ileum in intact humans. Influence of meal residue and ileal motility. Gastroenterology, 92:724–9.
   PubMed Web of Science ®Google Scholar
• Bettini R, Catellani PL, Santi P, Massimo G, Peppas NA, Colombo P. (2001). Translocation of drug particles in HPMC matrix gel layer: Effect of drug solubility and influence on release rate. J Control Release, 70:383–91.
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Santi P, De Ascentiis A, Peppas NA. (1996). Analysis of the swelling and release mechanism from the drug delivery systems with emphasis on drug solubility and water transport. J Control Release, 39:231–7.
   Web of Science ®Google Scholar
• Jantratid E, Janssen N, Reppas C, Dressman JB. (2008). Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update. Pharm Res, 25:1663–76.
   PubMed Web of Science ®Google Scholar
• Kalantzi L, Goumas K, Kalioras V, Abrahamsson B, Dressman JB, Reppas C. (2006). Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res, 23:165–76.
   PubMed Web of Science ®Google Scholar
• Zoeller T, Klein S. (2007). Simplified biorelevant media for screening dissolution performance of poorly soluble drugs. Dissol Technol, 14:8–13.
   Web of Science ®Google Scholar